Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Pharmaceuticals LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.30p -2.47% 90.80p 91.00p 91.90p 93.20p 91.00p 93.20p 20,509 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 46.3 -113.6 -31.0 - 302.79

Circassia Pharmaceuticals Plc Block listing Interim Review

18/05/2018 10:57am

UK Regulatory (RNS & others)


Circassia (LSE:CIR)
Historical Stock Chart

1 Month : From Apr 2018 to May 2018

Click Here for more Circassia Charts.

TIDMCIR

RNS Number : 5783O

Circassia Pharmaceuticals Plc

18 May 2018

18 May 2018

Circassia Pharmaceuticals plc

Block Listing Application

Circassia Pharmaceuticals plc ("Circassia" or "the Company") today announces that an application (the "Application") has been made to the UK Listing Authority and the London Stock Exchange for a block listing of 400,000 ordinary shares of 0.08 pence each in the Company ("Ordinary Shares") to be admitted to trading on the Premium Segment of the London Stock Exchange.

The Application relates to Ordinary Shares to be issued from time to time in order to satisfy the potential exercise of share options granted under the 2015 Performance Share Plan Scheme.

It is expected that admission will become effective on 21 May 2018. When issued, the Ordinary Shares will rank pari passu with the existing ordinary shares of the Company.

As at today, there are 333,466,262 ordinary shares in issue with one voting right per share. The Company does not hold any shares in treasury. The Company will notify on a monthly basis when there are changes to the issued share capital of the Company, and these monthly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

-Ends-

For further information, please contact:

 
 Circassia Pharmaceuticals 
  plc 
 Julien Cotta, Company       Tel: +44 (0) 1865 405 
  Secretary                   560 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

BLRGGUMAAUPRUBR

(END) Dow Jones Newswires

May 18, 2018 05:57 ET (09:57 GMT)

1 Year Circassia Chart

1 Year Circassia Chart

1 Month Circassia Chart

1 Month Circassia Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20180526 08:25:53